Goro Fujiki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Goro Fujiki has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Morita
2 shared publicationsAtsushi Nakagawa
Department of Cardiology, Nippon Life Hospital , Osaka
1 shared publication- Hideaki Morita
Department of Cardiology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan
1 shared publication Hideo Fujita
Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Omiya, Japan
1 shared publicationHiroki Shinohara
Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan
1 shared publicationHiroshi Akazawa
Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Coronary stent infection causing perforation and thrombotic occlusion after early post-PCI MRSA bacteraemia: an autopsy case report
Background: Coronary stent infection (CSI) is rare but can be fatal. In Staphylococcus aureus bacteraemia (SAB), treatment duration is guided by classification as uncomplicated or complicated SAB. However, whether a recently implanted drug-eluting stent (DES) should be regarded as intravascular prosthetic material remains unclear. Case Summary: An 83-year-old woman underwent PCI for a severely calcified right coronary ostial lesion. After rotational atherectomy, a DES was implanted, and final angiography showed adequate expansion. On hospital day 7, cellulitis developed at a peripheral intravenous catheter site. Blood and skin cultures grew methicillin-resistant Staphylococcus aureus (MRSA). Intravenous linezolid was started because of renal dysfunction. The episode was considered to be uncomplicated SAB because follow-up blood cultures were negative, fever resolved, transthoracic echocardiography showed no vegetation, and no metastatic infection was identified. Antimicrobial therapy was stopped after 14 days. Fever and inflammatory markers did not recur, but nonspecific chest symptoms persisted. Follow-up coronary angiography showed no clear abnormalities. After discharge, MRSA bacteraemia recurred. The patient developed shock with inferior ST-segment elevation, followed by pulseless electrical activity and death. Autopsy revealed coronary wall disruption, surrounding haemorrhage, ostial thrombotic occlusion, gram-positive cocci, and neutrophilic infiltration near the right coronary ostial stent, leading to the diagnosis of CSI. Discussion: This case raises the possibility that a recently implanted DES may serve as an occult endovascular focus during SAB. Negative follow-up blood cultures, defervescence, normalised inflammatory markers, and unrevealing imaging may not exclude CSI; persistent or recurrent chest symptoms after recent PCI should prompt targeted reassessment.
- 8 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Open AccessCoronary stent infection causing perforation and thrombotic occlusion after early post-PCI MRSA bacteraemia: an autopsy case report
Background: Coronary stent infection (CSI) is rare but can be fatal. In Staphylococcus aureus bacteraemia (SAB), treatment duration is guided by classification as uncomplicated or complicated SAB. However, whether a recently implanted drug-eluting stent (DES) should be regarded as intravascular prosthetic material remains unclear. Case Summary: An 83-year-old woman underwent PCI for a severely calcified right coronary ostial lesion. After rotational atherectomy, a DES was implanted, and final angiography showed adequate expansion. On hospital day 7, cellulitis developed at a peripheral intravenous catheter site. Blood and skin cultures grew methicillin-resistant Staphylococcus aureus (MRSA). Intravenous linezolid was started because of renal dysfunction. The episode was considered to be uncomplicated SAB because follow-up blood cultures were negative, fever resolved, transthoracic echocardiography showed no vegetation, and no metastatic infection was identified. Antimicrobial therapy was stopped after 14 days. Fever and inflammatory markers did not recur, but nonspecific chest symptoms persisted. Follow-up coronary angiography showed no clear abnormalities. After discharge, MRSA bacteraemia recurred. The patient developed shock with inferior ST-segment elevation, followed by pulseless electrical activity and death. Autopsy revealed coronary wall disruption, surrounding haemorrhage, ostial thrombotic occlusion, gram-positive cocci, and neutrophilic infiltration near the right coronary ostial stent, leading to the diagnosis of CSI. Discussion: This case raises the possibility that a recently implanted DES may serve as an occult endovascular focus during SAB. Negative follow-up blood cultures, defervescence, normalised inflammatory markers, and unrevealing imaging may not exclude CSI; persistent or recurrent chest symptoms after recent PCI should prompt targeted reassessment.
- Open Access
- 22 July 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7)
A No-Code, Guideline-Based Custom GPT Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis
- 22 July 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7)
Open AccessA No-Code, Guideline-Based Custom GPT Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis
- Open Access
- 10 December 2024
- Published by Elsevier in JACC: Asia
- Vol. 5 (1) , 88-98
Deep Learning-Based Identification of Echocardiographic Abnormalities From Electrocardiograms
- 10 December 2024
- Published by Elsevier in JACC: Asia
- Vol. 5 (1) , 88-98
Open AccessDeep Learning-Based Identification of Echocardiographic Abnormalities From Electrocardiograms